TY - JOUR
T1 - Synthesis of 4- and 5-arylthiazolinethiones as inhibitors of indoleamine 2,3-dioxygenase
AU - Balti, Monaem
AU - Plas, Aurélie
AU - Meinguet, Céline
AU - Haufroid, Marie
AU - Thémans, Quentin
AU - Efrit, Mohamed Lotfi
AU - Wouters, Johan
AU - Lanners, Steve
N1 - Copyright © 2016 Elsevier Ltd. All rights reserved.
PY - 2017/8/1
Y1 - 2017/8/1
N2 - Docking studies of 4-phenylthiazolinethione on human IDO1 suggest complexation of the heme iron by the exocyclic sulfur atom further reinforced by hydrophobic interactions of the phenyl ring within pocket A of the enzyme. On this basis, chemical modifications were proposed to increase inhibition activity. Synthetic routes had to be adapted and optimized to yield the desired substituted 4- and 5-arylthiazolinethiones. Their biological evaluation shows that 5-aryl regioisomers are systematically less potent than the corresponding 4-aryl analogs. Substitution on the phenyl ring does not significantly increase inhibition potency, except for 4-Br and 4-Cl derivatives.
AB - Docking studies of 4-phenylthiazolinethione on human IDO1 suggest complexation of the heme iron by the exocyclic sulfur atom further reinforced by hydrophobic interactions of the phenyl ring within pocket A of the enzyme. On this basis, chemical modifications were proposed to increase inhibition activity. Synthetic routes had to be adapted and optimized to yield the desired substituted 4- and 5-arylthiazolinethiones. Their biological evaluation shows that 5-aryl regioisomers are systematically less potent than the corresponding 4-aryl analogs. Substitution on the phenyl ring does not significantly increase inhibition potency, except for 4-Br and 4-Cl derivatives.
KW - 4-Phenyl thiazolinethione
KW - Anti-cancer
KW - Aryl-thiazoline thione
KW - IDO inhibition
KW - Indoleamine 2,3-dioxygenase (IDO)
KW - Indoleamine-Pyrrole 2,3,-Dioxygenase/antagonists & inhibitors
KW - Stereoisomerism
KW - Humans
KW - Thiones/chemical synthesis
KW - Thiazolidines/chemical synthesis
KW - Structure-Activity Relationship
KW - Molecular Docking Simulation
KW - Enzyme Inhibitors/chemical synthesis
UR - http://www.scopus.com/inward/record.url?scp=85021225997&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2016.06.052
DO - 10.1016/j.bmcl.2016.06.052
M3 - Article
C2 - 28651980
AN - SCOPUS:85021225997
SN - 0960-894X
VL - 27
SP - 3607
EP - 3610
JO - Bioorganic and medicinal chemistry letters
JF - Bioorganic and medicinal chemistry letters
IS - 15
ER -